GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mangalam Drugs & Organics Ltd (NSE:MANGALAM) » Definitions » Total Long-Term Liabilities

Mangalam Drugs & Organics (NSE:MANGALAM) Total Long-Term Liabilities : ₹238 Mil (As of Sep. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Mangalam Drugs & Organics Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Mangalam Drugs & Organics's Total Long-Term Liabilities for the quarter that ended in Sep. 2024 was ₹238 Mil.

Mangalam Drugs & Organics Total Long-Term Liabilities Historical Data

The historical data trend for Mangalam Drugs & Organics's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mangalam Drugs & Organics Total Long-Term Liabilities Chart

Mangalam Drugs & Organics Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 172.61 242.45 477.51 423.15 338.46

Mangalam Drugs & Organics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 391.92 - 338.46 - 237.71

Mangalam Drugs & Organics Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Mangalam Drugs & Organics Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Mangalam Drugs & Organics's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Mangalam Drugs & Organics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mangalam Drugs & Organics Ltd (NSE:MANGALAM) » Definitions » Total Long-Term Liabilities
Comparable Companies
BOM:531173 BOM:532878 BOM:524518 BOM:532384 BOM:530313 BOM:537536 NSE:VAISHALI BOM:524824 NSE:SOTAC BOM:531739 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
532637:India
Address
P. D'Mello Road, Rupam Building, 3rd Floor, No. 239, Near General Post Office, Mumbai, MH, IND, 400001
Website
https://www.mangalamdrugs.com
Mangalam Drugs & Organics Ltd is an Indian company operating in the healthcare sector. The company is engaged in the research and development and manufacturing of drugs. Its product range includes Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty chemicals. Its sales comprise sales in the Indian and overseas markets. The single operating segment of the company is the Manufacturing of Bulk Drugs.

Mangalam Drugs & Organics Headlines

No Headlines